International Journal of Cancer Management
The Official Journal of Cancer Research Center (CRC), Shahid Beheshti University of Medical Sciences
Image Credit:Int J Cancer Manag
The Significance of Bladder Cancer in Iran
Acknowledgments
Footnotes
AI Use Disclosure:The authors declare that no generative AI tools were used to create this article.
Authors' Contribution:Sirous Rafiei Asl performed study conceptualization and design, data analysis and interpretation, critical revision of the manuscript, and study supervision; Safa Najafi collected the data and drafted the manuscript.
Conflict of Interests Statement:The authors declare no conflicts of interest. Sirous Rafiei Asl is a faculty member at Ahvaz Jundishapur University of Medical Sciences and a reviewer for this journal.
Funding/Support:The authors received no funding for this study.
References
- 1.Najafi S, Askarykia J, Rafiei Asl S, Sarkarian M. Risk factors associated with bladder cancer based on pathological results: A case–control study in Ahvaz. Trans Res Urol. 2026. e245301. https://doi.org/10.22034/tru.2026.580249.1337.
- 2.Yashaswini C. Epidemiology and risk factors of bladder cancer. In: Prajapati BG, Kapoor DU, AlAsmari AF, editors. Bladder Cancer Breakthroughs. Academic Press; 2026. p. 1-12.
- 3.Cumberbatch MGK, Jubber I, Black PC, Esperto F, Figueroa JD, Kamat AM, et al. Epidemiology of bladder cancer: A systematic review and contemporary update of risk factors in 2018. Eur Urol. 2018;74(6):784-795. [PubMed ID: 30268659]. https://doi.org/10.1016/j.eururo.2018.09.001.
- 4.Hosseini AS, Jalali SM, Shateri Z, Shoja M, Rajabzadeh-Dehkordi M, Makhtoomi M, et al. The association between digestion-resistant and bioactive peptide content of dairy products and bladder cancer: A case-control study. J Health Popul Nutr. 2025;44(1):336. [PubMed ID: 41029398]. [PubMed Central ID: PMC12486994]. https://doi.org/10.1186/s41043-025-01071-2.
- 5.Abdolahinia Z, Mirzaee M, Pakmanesh H, Bazrafshan A, Shafiei Bafti M, Shahesmaeili A. Prevalence of bladder cancer in the Kerman Province, Southeastern Iran, using the complete prevalence method. Journal of Occupational Health and Epidemiology. 2022;11(3):180-186. https://doi.org/10.61186/johe.11.3.180.
- 6.Hadji M, Rashidian H, Marzban M, Naghibzadeh-Tahami A, Gholipour M, Mohebbi E, et al. Opium use and risk of bladder cancer: A multi-centre case-referent study in Iran. Int J Epidemiol. 2022;51(3):830-838. [PubMed ID: 35244716]. [PubMed Central ID: PMC9189939]. https://doi.org/10.1093/ije/dyac031.
- 7.Rashidian H, Haghdoost AA, Daroudi R, Raadabadi M, Ebadzadeh MR, Zendehdel K. Estimating the prevalence of bladder cancer by stage in Iran as a developing country. Med J Islam Repub Iran. 2022;36:37. [PubMed ID: 36128281]. [PubMed Central ID: PMC9448492]. https://doi.org/10.47176/mjiri.36.37.
- 8.Nowroozi MR, Amini E, Farkhani EM, Nowroozi A, Ayati M, Momeni SA, et al. National and subnational incidence trend of bladder cancer in Iran: Report of a 12-year period. Int J Cancer Manag. 2023;16(1). e127005. https://doi.org/10.5812/ijcm-127005.
- 9.Sadeghi A, Nouri F, Dehdari Ebrahimi N, Taherifard E, Soltani M, Williams SB, et al. Bladder cancer in the United States: National trends and state-level patterns from Global Burden of Disease (GBD) study, 1980-2021. medRxiv. 2026. https://doi.org/10.64898/2026.07.11.26357810.
- 10.Joyce DD, Sharma V, Williams SB. Cost-effectiveness and economic impact of bladder cancer management: An updated review of the literature. Pharmacoeconomics. 2023;41(7):751-769. [PubMed ID: 37088844]. https://doi.org/10.1007/s40273-023-01273-8.
Copyright
Copyright © 2026, Najafi and Rafiei Asl. This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Similar Articles
Characteristics of Patients With Transitional Cell Carcinoma of the Urinary Bladder in Kermanshah Province, Iran
Payandeh M, Sadeghi M, Sadeghi E. Characteristics of Patients With Transitional Cell Carcinoma of the Urinary Bladder in Kermanshah Province, Iran. Int J Cancer Manag. 2015;8(6):e4038. doi: https://doi.org/10.17795/ijcp-4038
Cancers of Urinary System; Prevalence, Demographic
Tolou Ghamari Z. Cancers of Urinary System; Prevalence, Demographic. Jundishapur J Chronic Dis Care. 2019;8(4):e95732. doi: https://doi.org/10.5812/jjcdc.95732
National and Subnational Incidence Trend of Bladder Cancer in Iran: Report of a 12-Year Period
Nowroozi MR, Amini E, Farkhani EM, Nowroozi A, Ayati M, et al. National and Subnational Incidence Trend of Bladder Cancer in Iran: Report of a 12-Year Period. Int J Cancer Manag. 2023;16(1):e127005. doi: https://doi.org/10.5812/ijcm-127005
Bladder Cancer in Iran: Geographical Distribution and Risk Factors
Jafari-Koshki T, Arsang-Jang S, Mahaki B. Bladder Cancer in Iran: Geographical Distribution and Risk Factors. Int J Cancer Manag. 2017;10(2):e5610. doi: https://doi.org/10.5812/ijcp.5610
Survival Rate of Patients with Bladder Cancer in Yazd, Central Province of Iran
Vahedian-Ardakani H, Moghimi M, Shayestehpour M, Doosti M, Alimohammadi F. Survival Rate of Patients with Bladder Cancer in Yazd, Central Province of Iran. Int J Cancer Manag. 2018;11(5):e61436. doi: https://doi.org/10.5812/ijcm.61436